FDA Approves Pfizer's Ruxience Rituximab Biosimilar

 
• By David Wallace
  
FDA Approved
FDA Approval Has Been Received, But Launch Plans Are Still Under Lock And Key • Source: Shutterstock

More from Biosimilars

More from Products